Skip to content

Application of ultrasound-guided intramural block of supraclavicular brachial plexus in clinical anesthesia

Application of ultrasound-guided intramural block of supraclavicular brachial plexus in clinical anesthesia

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082191
Enrollment
Unknown
Registered
2024-03-22
Start date
2023-01-11
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brachial plexus block anesthesia for upper limb trauma

Interventions

intervention group:Ultrasound guided supraclavicular intrathecal brachial plexus block
control group:Ultrasound-guided intrathecal block anesthesia of supraclavicular brachial plexus
experimental group:During ultrasound-guided intrathecal block anesthesia of supraclavicular brachial plexus, additional baffle pressure was applied

Sponsors

Wuxi 9th People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 60 Years

Inclusion criteria

Inclusion criteria: Part I Inclusion criteria: (1)Planned elective surgery on the hand, wrist and forearm of one upper limb, gender unrestricted. (2)Age 18-60 years old; (3) Patients with American Society of Anesthesiologists (ASA) Class I-II health status; (4) BMI between 18 and 30kg/m2; (5) Patients who voluntarily joined the study and signed the informed consent for the study. Part II Inclusion criteria: (1) Age 18-60 (2) ASA grade I-II (3) The right upper limb hand, wrist and forearm surgery is to be performed (4) It can be used to measure diaphragmatic activity and respiratory function (5) Agree to participate in the study and sign the anesthesia informed consent

Exclusion criteria

Exclusion criteria: Part One Exclusion Criteria: (1) Pregnancy and lactation (2) Systemic diseases contraindicated for brachial plexus block or inability to clearly display the brachial plexus fascial sheath (3) Patients with mental disorders or those taking psychotropic drugs (4) Patients with chronic pain, long-term use of non-steroidal anti-inflammatory drugs or long-term use of opioid drugs (5) Uncontrolled diabetes, epilepsy, obstructive pulmonary disease and neuromuscular diseases (6) History of trauma or surgery in the supraclavicular region (7) Patients with coagulation disorders Part Two Exclusion Criteria: (1) Patients or their families refuse to participate in the study (2) Pregnant and lactating women (3) Allergy to ropivacaine or other amide local anesthetics (4) History of alcohol abuse or drug addiction (5) Coagulation disorders (6) History of severe systemic diseases or chronic heart and lung diseases (7) Diaphragmatic dysfunction or inability to measure diaphragmatic activity by ultrasound in patients (8) Presence of nerve injury or diabetic neuropathy (9) History of chronic opioid use (10) History of consciousness disorders or mental illness (11) Infection at the puncture site or history of trauma or surgery (12) BMI between 18 and 30 kg/m2

Design outcomes

Primary

MeasureTime frame
Onset time of block;Diaphragm movement;

Secondary

MeasureTime frame
Lung function;Onset time of sensory block;Motor block time;Sensory recovery time;Postoperative patient;Maximum injection pressure;

Countries

China

Contacts

Public ContactTongsheng Xu

Wuxi Ninth People's Hospital Affiliated to Soochow University

xutongs@126.com+86 159 6172 0618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026